Press Release

CSRxP: SOTU 2020 OFFERS PRESIDENT UNIQUE MOMENT TO LEAD ON LOWERING Rx PRICES

Feb 3, 2020

Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable & Read More

CSRXP APPLAUDS SENATE PASSAGE OF USMCA THAT PUTS AMERICAN PATIENTS FIRST

Jan 16, 2020

Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision Read More

CSRXP: BIG PHARMA THUMBS ITS NOSE AT STRUGGLING AMERICANS WITH NEW YEAR PRICE HIKES

Jan 2, 2020

Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More Read More

CSRXP: THE HOUSE HAS ACTED, TIME FOR SENATE TO DO ITS JOB

Dec 12, 2019

Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress Read More

CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D

Dec 10, 2019

Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times Read More

CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE

Nov 22, 2019

Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers Read More

CSRxP: Policymakers Must Remove Big Pharma Carveout in USMCA

Oct 23, 2019

Washington Can Put Patients First By Amending Trade Provision That Would Read More

CSRXP URGES HOUSE LAWMAKERS TO CONTINUE WORKING ACROSS PARTY LINES TO HOLD BIG PHARMA ACCOUNTABLE

Oct 16, 2019

Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas Read More

CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus

Sep 23, 2019

Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of Read More

CSRxP: House Rx Package Adds to Unprecedented Momentum to Hold Big Pharma Accountable

Sep 19, 2019

Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from Read More

CSRxP: HHS OIG REPORT DRASTICALLY UNDERCUTS BIG PHARMA’S BLAME GAME AT CRITICAL MOMENT IN WASHINGTON

Sep 13, 2019

Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes, Read More

NEW STUDY: BIG PHARMA PRICE-GOUGING MEDICATIONS FOR RARE DISEASES AT STAGGERING RATE

Sep 11, 2019

Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs Read More